Morgan Stanley Upgrades Amicus Therapeutics (FOLD) to Overweight
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 20 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung upgraded Amicus Therapeutics (NASDAQ: FOLD) from Equalweight to Overweight with a price target of $20.00 (from $15.00).
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $12.66 yesterday.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Samsonite International SA (1910:HK) (SMSEY) PT Lowered to HK$19.60 at Macquarie
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
